Delivery Order SPE2DB22D2206-SPE2DB25FEH45

Award Date 11/19/24
Potential Completion Date 11/20/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $1,412.94, is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. The award...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,271.43 for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM. The contract was awarded by the Defense Logistics Agency (DLA), which is a defense agency that provides worldwide logistics support to the U.S. military and other government agencies. The contract is a firm fixed-price arrangement with a period of performance extending through May 16, 2025....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,939.66, is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a medical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,407.36 delivery order contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract is a firm fixed-price agreement with an ultimate completion date of March 26, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,042.61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of budesonide-formoterol 160-4.5 10.2GM, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award is a delivery order valued at $3,166.13 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a period of performance through July 2, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,629.62, is a Delivery Order for Budesonide-Formoterol 80-4.5 10.2GM medication, with a completion date of January 28, 2025. The contract is a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $12,373.47 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes,...
This federal contract award, valued at $14,295.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product, with a performance period extending through May 8, 2025. The contract is a firm fixed-price, non-set-aside arrangement, indicating open competition. Amerisourcebergen Drug Corp...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,457.34 firm-fixed-price delivery order is for the supply of medical products and pharmaceuticals, including Bude-Formoterol, to support federal healthcare programs and facilities. The contract does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEH45
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $13,317.81 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The IDC with the DLA is valued at $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/18/25, 1:41 PM